vs
Side-by-side financial comparison of USANA HEALTH SCIENCES INC (USNA) and UNIVERSAL TECHNICAL INSTITUTE INC (UTI). Click either name above to swap in a different company.
USANA HEALTH SCIENCES INC is the larger business by last-quarter revenue ($226.2M vs $220.8M, roughly 1.0× UNIVERSAL TECHNICAL INSTITUTE INC). UNIVERSAL TECHNICAL INSTITUTE INC runs the higher net margin — 5.8% vs 0.1%, a 5.7% gap on every dollar of revenue. On growth, UNIVERSAL TECHNICAL INSTITUTE INC posted the faster year-over-year revenue change (9.6% vs -10.0%). Over the past eight quarters, UNIVERSAL TECHNICAL INSTITUTE INC's revenue compounded faster (9.5% CAGR vs -0.4%).
Usana Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, Usana was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 24 countries via a network of independent distributors.
Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.
USNA vs UTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $226.2M | $220.8M |
| Net Profit | $180.0K | $12.8M |
| Gross Margin | 78.2% | — |
| Operating Margin | 1.7% | 7.1% |
| Net Margin | 0.1% | 5.8% |
| Revenue YoY | -10.0% | 9.6% |
| Net Profit YoY | -74.0% | -42.1% |
| EPS (diluted) | $-0.10 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $226.2M | $220.8M | ||
| Q3 25 | $213.7M | $222.4M | ||
| Q2 25 | $235.8M | $204.3M | ||
| Q1 25 | $249.5M | $207.4M | ||
| Q4 24 | $213.6M | $201.4M | ||
| Q3 24 | $200.2M | $196.4M | ||
| Q2 24 | $212.9M | $177.5M | ||
| Q1 24 | $227.8M | $184.2M |
| Q4 25 | $180.0K | $12.8M | ||
| Q3 25 | $-6.5M | $18.8M | ||
| Q2 25 | $9.7M | $10.7M | ||
| Q1 25 | $9.4M | $11.4M | ||
| Q4 24 | $4.5M | $22.2M | ||
| Q3 24 | $10.6M | $18.8M | ||
| Q2 24 | $10.4M | $5.0M | ||
| Q1 24 | $16.5M | $7.8M |
| Q4 25 | 78.2% | — | ||
| Q3 25 | 77.2% | — | ||
| Q2 25 | 78.7% | — | ||
| Q1 25 | 79.0% | — | ||
| Q4 24 | 82.0% | — | ||
| Q3 24 | 80.4% | — | ||
| Q2 24 | 81.1% | — | ||
| Q1 24 | 81.1% | — |
| Q4 25 | 1.7% | 7.1% | ||
| Q3 25 | 0.6% | 11.2% | ||
| Q2 25 | 7.1% | 6.9% | ||
| Q1 25 | 6.3% | 8.1% | ||
| Q4 24 | 3.8% | 13.6% | ||
| Q3 24 | 7.8% | 13.3% | ||
| Q2 24 | 8.4% | 4.2% | ||
| Q1 24 | 10.8% | 6.1% |
| Q4 25 | 0.1% | 5.8% | ||
| Q3 25 | -3.1% | 8.4% | ||
| Q2 25 | 4.1% | 5.2% | ||
| Q1 25 | 3.8% | 5.5% | ||
| Q4 24 | 2.1% | 11.0% | ||
| Q3 24 | 5.3% | 9.6% | ||
| Q2 24 | 4.9% | 2.8% | ||
| Q1 24 | 7.3% | 4.2% |
| Q4 25 | $-0.10 | $0.23 | ||
| Q3 25 | $-0.36 | $0.33 | ||
| Q2 25 | $0.52 | $0.19 | ||
| Q1 25 | $0.49 | $0.21 | ||
| Q4 24 | $0.23 | $0.40 | ||
| Q3 24 | $0.56 | $0.35 | ||
| Q2 24 | $0.54 | $0.09 | ||
| Q1 24 | $0.86 | $0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.4M | $162.8M |
| Total DebtLower is stronger | — | $101.4M |
| Stockholders' EquityBook value | — | $335.9M |
| Total Assets | $742.9M | $834.0M |
| Debt / EquityLower = less leverage | — | 0.30× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $158.4M | $162.8M | ||
| Q3 25 | $145.3M | $169.1M | ||
| Q2 25 | $151.3M | $70.7M | ||
| Q1 25 | $179.6M | $96.0M | ||
| Q4 24 | $181.8M | $172.0M | ||
| Q3 24 | $364.9M | $161.9M | ||
| Q2 24 | $332.4M | $115.5M | ||
| Q1 24 | $328.3M | $116.1M |
| Q4 25 | — | $101.4M | ||
| Q3 25 | — | $87.1M | ||
| Q2 25 | — | $73.8M | ||
| Q1 25 | — | $94.4M | ||
| Q4 24 | — | $120.1M | ||
| Q3 24 | — | $125.7M | ||
| Q2 24 | — | $137.3M | ||
| Q1 24 | — | $141.9M |
| Q4 25 | — | $335.9M | ||
| Q3 25 | $528.1M | $328.1M | ||
| Q2 25 | $531.1M | $306.8M | ||
| Q1 25 | $529.8M | $293.9M | ||
| Q4 24 | $532.1M | $280.0M | ||
| Q3 24 | $533.1M | $260.2M | ||
| Q2 24 | $512.2M | $239.4M | ||
| Q1 24 | $500.0M | $232.6M |
| Q4 25 | $742.9M | $834.0M | ||
| Q3 25 | $726.6M | $826.1M | ||
| Q2 25 | $734.5M | $740.8M | ||
| Q1 25 | $746.6M | $720.4M | ||
| Q4 24 | $748.2M | $753.8M | ||
| Q3 24 | $671.3M | $744.6M | ||
| Q2 24 | $631.4M | $706.0M | ||
| Q1 24 | $629.3M | $702.1M |
| Q4 25 | — | 0.30× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.24× | ||
| Q1 25 | — | 0.32× | ||
| Q4 24 | — | 0.43× | ||
| Q3 24 | — | 0.48× | ||
| Q2 24 | — | 0.57× | ||
| Q1 24 | — | 0.61× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $3.1M |
| Free Cash FlowOCF − Capex | — | $-19.2M |
| FCF MarginFCF / Revenue | — | -8.7% |
| Capex IntensityCapex / Revenue | — | 10.1% |
| Cash ConversionOCF / Net Profit | — | 0.24× |
| TTM Free Cash FlowTrailing 4 quarters | — | $16.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $3.1M | ||
| Q3 25 | $-2.0M | $57.1M | ||
| Q2 25 | $12.2M | $18.1M | ||
| Q1 25 | $15.5M | $-789.0K | ||
| Q4 24 | $5.8M | $23.0M | ||
| Q3 24 | $29.5M | $67.5M | ||
| Q2 24 | $8.0M | $10.0M | ||
| Q1 24 | $17.7M | $-2.5M |
| Q4 25 | — | $-19.2M | ||
| Q3 25 | $-5.2M | $40.6M | ||
| Q2 25 | $7.2M | $6.8M | ||
| Q1 25 | $12.7M | $-11.7M | ||
| Q4 24 | $4.0M | $19.6M | ||
| Q3 24 | $27.1M | $60.0M | ||
| Q2 24 | $5.3M | $3.0M | ||
| Q1 24 | $14.5M | $-8.4M |
| Q4 25 | — | -8.7% | ||
| Q3 25 | -2.4% | 18.3% | ||
| Q2 25 | 3.0% | 3.4% | ||
| Q1 25 | 5.1% | -5.7% | ||
| Q4 24 | 1.9% | 9.7% | ||
| Q3 24 | 13.6% | 30.6% | ||
| Q2 24 | 2.5% | 1.7% | ||
| Q1 24 | 6.4% | -4.6% |
| Q4 25 | — | 10.1% | ||
| Q3 25 | 1.5% | 7.4% | ||
| Q2 25 | 2.1% | 5.5% | ||
| Q1 25 | 1.1% | 5.3% | ||
| Q4 24 | 0.8% | 1.7% | ||
| Q3 24 | 1.2% | 3.8% | ||
| Q2 24 | 1.3% | 4.0% | ||
| Q1 24 | 1.4% | 3.2% |
| Q4 25 | — | 0.24× | ||
| Q3 25 | — | 3.04× | ||
| Q2 25 | 1.27× | 1.69× | ||
| Q1 25 | 1.65× | -0.07× | ||
| Q4 24 | 1.29× | 1.04× | ||
| Q3 24 | 2.78× | 3.58× | ||
| Q2 24 | 0.77× | 2.01× | ||
| Q1 24 | 1.07× | -0.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
USNA
Segment breakdown not available.
UTI
| UTI | $142.8M | 65% |
| Concorde | $78.0M | 35% |
